Furthermore, there are controversy regarding the interchangeability of PD-L1 clones type approved as companion for some specific drugs in specific types of cancer, although some studies demonstrated a strong correlation of immunohistochemical expression between some clones such as 22C3 and SP26345,46. This evidence concerns the gene CD274 and cancer.